Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1970 1
1972 1
1979 2
1980 1
1982 1
1987 2
1991 3
1993 1
1994 3
1995 1
1996 3
1997 5
1998 5
1999 4
2000 3
2001 3
2002 4
2003 3
2004 3
2005 4
2006 7
2007 6
2008 12
2009 13
2010 11
2011 4
2012 4
2013 9
2014 5
2015 7
2016 10
2017 9
2018 12
2019 11
2020 11
2021 12
2022 9
2023 8
2024 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Results by year

Filters applied: . Clear all
Page 1
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer.
Tarantino P, Viale G, Press MF, Hu X, Penault-Llorca F, Bardia A, Batistatou A, Burstein HJ, Carey LA, Cortes J, Denkert C, Diéras V, Jacot W, Koutras AK, Lebeau A, Loibl S, Modi S, Mosele MF, Provenzano E, Pruneri G, Reis-Filho JS, Rojo F, Salgado R, Schmid P, Schnitt SJ, Tolaney SM, Trapani D, Vincent-Salomon A, Wolff AC, Pentheroudakis G, André F, Curigliano G. Tarantino P, et al. Among authors: lebeau a. Ann Oncol. 2023 Aug;34(8):645-659. doi: 10.1016/j.annonc.2023.05.008. Epub 2023 Jun 1. Ann Oncol. 2023. PMID: 37269905 Free article. Review.
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, Lebeau A, Liedtke C, von Minckwitz G, Nekljudova V, Schmatloch S, Schrenk P, Staebler A, Untch M. Kuehn T, et al. Among authors: lebeau a. Lancet Oncol. 2013 Jun;14(7):609-18. doi: 10.1016/S1470-2045(13)70166-9. Epub 2013 May 15. Lancet Oncol. 2013. PMID: 23683750
[Breast pathology update].
Lebeau A. Lebeau A. Pathologie (Heidelb). 2023 Feb;44(1):3-4. doi: 10.1007/s00292-022-01179-w. Epub 2023 Jan 25. Pathologie (Heidelb). 2023. PMID: 36695829 German. No abstract available.
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines.
Schünemann HJ, Lerda D, Quinn C, Follmann M, Alonso-Coello P, Rossi PG, Lebeau A, Nyström L, Broeders M, Ioannidou-Mouzaka L, Duffy SW, Borisch B, Fitzpatrick P, Hofvind S, Castells X, Giordano L, Canelo-Aybar C, Warman S, Mansel R, Sardanelli F, Parmelli E, Gräwingholt A, Saz-Parkinson Z; European Commission Initiative on Breast Cancer (ECIBC) Contributor Group. Schünemann HJ, et al. Among authors: lebeau a. Ann Intern Med. 2020 Jan 7;172(1):46-56. doi: 10.7326/M19-2125. Epub 2019 Nov 26. Ann Intern Med. 2020. PMID: 31766052 Free article.
Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
Hubert P, Roncarati P, Demoulin S, Pilard C, Ancion M, Reynders C, Lerho T, Bruyere D, Lebeau A, Radermecker C, Meunier M, Nokin MJ, Hendrick E, Peulen O, Delvenne P, Herfs M. Hubert P, et al. Among authors: lebeau a. J Immunother Cancer. 2021 Mar;9(3):e001966. doi: 10.1136/jitc-2020-001966. J Immunother Cancer. 2021. PMID: 33712445 Free PMC article.
HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources.
Lebeau A, Bruyere D, Roncarati P, Peixoto P, Hervouet E, Cobraiville G, Taminiau B, Masson M, Gallego C, Mazzucchelli G, Smargiasso N, Fleron M, Baiwir D, Hendrick E, Pilard C, Lerho T, Reynders C, Ancion M, Greimers R, Twizere JC, Daube G, Schlecht-Louf G, Bachelerie F, Combes JD, Melin P, Fillet M, Delvenne P, Hubert P, Herfs M. Lebeau A, et al. Nat Commun. 2022 Feb 28;13(1):1076. doi: 10.1038/s41467-022-28724-8. Nat Commun. 2022. PMID: 35228537 Free PMC article.
uPARAP/Endo180: a multifaceted protein of mesenchymal cells.
Gucciardo F, Pirson S, Baudin L, Lebeau A, Noël A. Gucciardo F, et al. Among authors: lebeau a. Cell Mol Life Sci. 2022 Apr 22;79(5):255. doi: 10.1007/s00018-022-04249-7. Cell Mol Life Sci. 2022. PMID: 35460056 Free PMC article. Review.
Development of an Engineered Single-Domain Antibody for Targeting MET in Non-Small Cell Lung Cancer.
Luo NY, Minne RL, Gallant JP, Gunaratne GS, West JL, Javeri S, Robertson AJ, Lake EW, Engle JW, Mixdorf JC, Aluicio-Sarduy E, Nickel KP, Hernandez R, Kimple RJ, Baschnagel AM, LeBeau AM. Luo NY, et al. Among authors: lebeau am. Bioconjug Chem. 2024 Mar 20;35(3):389-399. doi: 10.1021/acs.bioconjchem.4c00019. Epub 2024 Mar 12. Bioconjug Chem. 2024. PMID: 38470611
Locally advanced and metastatic endometrial cancer: Current and emerging therapies.
Salmon A, Lebeau A, Streel S, Dheur A, Schoenen S, Goffin F, Gonne E, Kridelka F, Kakkos A, Gennigens C. Salmon A, et al. Among authors: lebeau a. Cancer Treat Rev. 2024 Sep;129:102790. doi: 10.1016/j.ctrv.2024.102790. Epub 2024 Jun 22. Cancer Treat Rev. 2024. PMID: 38972136 Free article. Review.
203 results